Mutations on a key SARS-CoV-2 viral protein are linked to extreme immune responses and could offer a novel vaccine target.

A complex interplay of factors influences the spread of superbug genes during wastewater treatment and reuse.

Asma Al-Amoodi’s dream of becoming a scientist and working in the lab is coming true as she pursues her Ph.D. in bioscience at KAUST, under the mentorship of Jasmeen Merzaban

KAUST researchers have developed a gene-editing technique that provides a flexible and programmable platform for site-specific gene manipulations across all forms of DNA material.

Drugs that inhibit a key protein should offer new targeted cancer therapy for leukemia and breast cancer.

KAUST’s strategy presents new opportunities to accelerate our positive impact on the world through alignment with the Kingdom’s Vision 2030 Research, Development, and Innovation (RDI) priorities, enhancing our global and local partnerships, and focusing on commercialization and economic impact.

Less hazardous and more sensitive and eco-friendly scintillating compounds could greatly improve X-ray imaging technologies.

KAUST researchers work with Saudi hospitals to test novel approaches for early pathogen identification

Leena Ali Ibrahim’s research is revealing intricate brain connections between the senses that could have implications for finding treatments for autism and schizophrenia.

With his team, Prof. Łukasz Jaremko identified a dynamic behavior of certain proteins that make them potentially useful for targeted cancer therapy.

She was recognized for her groundbreaking work in developing data technology for disease surveillance, which has the ability to detect outbreaks of infectious diseases almost in real time.

Professor Peiying Hong has been honored as one of the four finalists for the prestigious 2023 Letten Prize Award.

Tiny packets of molecular cargo shed by cancer cells seed the foundations for metastasis at distant sites in the body.

The partnership seeks to leverage expertise in vaccine development, digital health systems, and biobanking to advance global health equity and foster innovative solutions in Saudi Arabia and beyond.

Biopharming technique yields cost-effective and environmentally friendly antimicrobial peptides.

Prof. Sahika Inal and her team are collaborating closely with Ashraf Dada, Fatima Alhamlan and co-workers at King Faisal Specialist Hospital and Research Centre (KFSH&RC) in Saudi Arabia. The aim of the partnership is to help develop and trial bioelectronic sensors that will aid in cheap, accurate and rapid pathogen detection.

An electronic sensor based on individual atoms anchored to MXene nanomaterials can detect tumor-specific biomarkers.

In a research partnership between KAUST, King Abdulaziz University, Jeddah (KAU) and King Abdulaziz University Hospital, Jeddah (KAUH), scientists have conducted a first-of-its-kind study in the Kingdom that compares stem cells derived from a unique cohort of Saudi Klinefelter patients with a group of North American and European descent.

Prof. Mo Li and Ph.D. student Chongwei Bi have developed a new single-cell sequencing technology that has revealed new details about mitochondrial mutations in human cells.